Biogen announces job cuts, turns focus to Alzheimer's drug launch
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Biogen (BIIB) tops earnings expectations, reveals workforce reduction
July 25, 2023 9:22 AM EDTBiogen (NASDAQ: BIIB) shares are trading higher premarket after topping second-quarter earnings and revenue expectations. The company also revealed it will cut jobs in order to save costs.
BIIB reported Q2 EPS of $4.02, $0.24 better than the analyst estimate of $3.78, while revenue for the quarter came... More
